PT  - JOURNAL ARTICLE
AU  - Gomes, M. Gabriela M.
AU  - Ferreira, Marcelo U.
AU  - Chikina, Maria
AU  - Pegden, Wesley
AU  - Aguas, Ricardo
TI  - Frailty variation models for susceptibility and exposure to SARS-CoV-2
AID  - 10.1101/2021.05.25.21257766
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.25.21257766
4099  - http://medrxiv.org/content/early/2021/07/25/2021.05.25.21257766.short
4100  - http://medrxiv.org/content/early/2021/07/25/2021.05.25.21257766.full
AB  - Individual variation in susceptibility and exposure is subject to selection by force of infection, accelerating the natural acquisition of immunity, and reducing herd immunity thresholds and epidemic final sizes. This is a manifestation of a wider population phenomenon known as “frailty variation” in demography. Despite this theoretical understanding, public health policies continue to be guided by mathematical models that leave out most of the relevant variation and as a result inflate projected infection burdens. Here we focus on the trajectories of the coronavirus disease (COVID-19) pandemic in England and Scotland. We fit models to series of daily deaths and estimate relevant epidemiological parameters, including coefficients of variation which we find in agreement with direct measurements based on published contact surveys. Our estimates are robust to whether the data series encompass one or two pandemic waves. We conclude that herd immunity thresholds are being reached with a larger contribution of vaccination in Scotland than in England, where naturally acquired immunity is higher. These results are relevant to global vaccination policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are publicly available. https://coronavirus.data.gov.uk/